Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model (Q34778476)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model (English)

1 reference

Europe PubMed Central

4 August 2017

0 references

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

12

object named as

Ulf Dittmer

1 reference

Europe PubMed Central

4 August 2017

author name string

Anna D Kosinska

1

1 reference

Europe PubMed Central

4 August 2017

Ejuan Zhang

2

1 reference

Europe PubMed Central

4 August 2017

Lena Johrden

3

1 reference

Europe PubMed Central

4 August 2017

Jia Liu

4

1 reference

Europe PubMed Central

4 August 2017

Pia L Seiz

5

1 reference

Europe PubMed Central

4 August 2017

Xiaoyong Zhang

6

1 reference

Europe PubMed Central

4 August 2017

Zhiyong Ma

7

1 reference

Europe PubMed Central

4 August 2017

Thekla Kemper

8

1 reference

Europe PubMed Central

4 August 2017

Melanie Fiedler

9

1 reference

Europe PubMed Central

4 August 2017

Dieter Glebe

10

1 reference

Europe PubMed Central

4 August 2017

Oliver Wildner

11

1 reference

Europe PubMed Central

4 August 2017

Mengji Lu

13

1 reference

Europe PubMed Central

4 August 2017

Michael Roggendorf

14

1 reference

Europe PubMed Central

4 August 2017

publication date

13 June 2013

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

9

1 reference

Europe PubMed Central

4 August 2017

6

1 reference

Europe PubMed Central

4 August 2017

e1003391

1 reference

Europe PubMed Central

4 August 2017

copyright license

Creative Commons Attribution 4.0 International

13 June 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The role of HBsAg quantification for monitoring natural history and treatment outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Clinical implications of HBsAg quantification in patients with chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Immune effectors required for hepatitis B virus clearance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Vaccination against hepatitis B and C: towards therapeutic application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Vaccines and immunotherapies against hepatitis B and hepatitis C viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Structure and glycosylation patterns of surface proteins from woodchuck hepatitis virus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Long-lasting memory T cell responses following self-limited acute hepatitis B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Evidence for long-range oncogene activation by hepadnavirus insertion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Hepatitis B virus immunopathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

The murine Kupffer cell. I. Characterization of the cell serving accessory function in antigen-specific T cell proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

7 July 2018

In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Long-term histologic and virologic outcomes of acute self-limited hepatitis B.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Specific Hepatitis B Vaccine Therapy in Inactive HBsAg Carriers: A Randomized Controlled Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

26 October 2018

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3681757

26 October 2018

Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: A multicenter clinical experience

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PPAT.1003391

21 January 2018

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers

1 reference

https://pubmed.ncbi.nlm.nih.gov/23785279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific vaccine therapy in chronic hepatitis B infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23785279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/23785279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks

1 reference

https://pubmed.ncbi.nlm.nih.gov/23785279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and limitations of a specific immunotherapy in chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/23785279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23785279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23785279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assay of hepatitis B surface antigen in serum or plasma using laurell electrophoresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23785279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PPAT.1003391

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34778476&oldid=1956787345"